Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-Infected Individuals”

Showing 20 of 0 results

Not applicableEnded earlyNCT02839603
What this trial is testing

Asymptomatic Leishmania Infection in HIV Patients

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 540
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT02786758
What this trial is testing

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals

Who this might be right for
Hepatitis CHIV
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 200
Large-scale testing (Phase 3)Study completedNCT00001082
What this trial is testing

The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 505
Post-approval studies (Phase 4)Ended earlyNCT01683656
What this trial is testing

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART

Who this might be right for
HIVAtherosclerosis
Calmy Alexandra 4
Post-approval studies (Phase 4)Study completedNCT03723525
What this trial is testing

Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals

Who this might be right for
HIV
National Centre for AIDs and STD Control, Nepal 1,073
Not applicableEnded earlyNCT01293123
What this trial is testing

Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

Who this might be right for
HIV
University of California, San Diego 2
Not applicableLooking for participantsNCT07425067
What this trial is testing

Upper Gastrointestinal Endoscopy in HIV-infected Individuals

Who this might be right for
HIV
Centre Hospitalier Universitaire Saint Pierre 2,500
Large-scale testing (Phase 3)Ended earlyNCT00986999
What this trial is testing

Effect of Rosuvastatin on Endothelial Function

Who this might be right for
HIV InfectionsCardiovascular Disease
University of Hawaii 7
Post-approval studies (Phase 4)Ended earlyNCT00632970
What this trial is testing

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Who this might be right for
HIV Infections
George Washington University 6
Post-approval studies (Phase 4)Looking for participantsNCT06762730
What this trial is testing

Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals

Who this might be right for
HIV Infected IndividualsOsteopenia
Hadassah Medical Organization 110
Not applicableNot Yet RecruitingNCT05752318
What this trial is testing

Analysis of the Persistence, Reservoir and HIV Latency

Who this might be right for
HIV Infected IndividualsInformed Consent
University Hospital, Strasbourg, France 500
Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Post-approval studies (Phase 4)Study completedNCT00148785
What this trial is testing

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

Who this might be right for
HIV Infections
Emory University 15
Early research (Phase 1)Ended earlyNCT03571204
What this trial is testing

Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 27
Post-approval studies (Phase 4)Study completedNCT00144352
What this trial is testing

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

Who this might be right for
MalariaHIVAIDS
Centers for Disease Control and Prevention 540
Early research (Phase 1)Study completedNCT02042248
What this trial is testing

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

Who this might be right for
HIV
Cynthia L Gay, MD 6
Large-scale testing (Phase 3)Study completedNCT03178084
What this trial is testing

Effects of Maraviroc vs. Efavirenz on CD4/CD8 Ratio

Who this might be right for
HIV/AIDS
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 721
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation